News

(Bloomberg) -- S&P Global Ratings put a positive outlook on Ireland’s credit rating, underscoring just how robust the country’s finances are ahead of next month’s general election.Most Read from BloombergUnder Trump, Prepare for New US Transportation PrioritiesZimbabwe City of 700,000 at Risk of Running Dry by Year-EndSaudi Neom Gets $3 Billion Loan Guarantee From Italy Export Credit Agency SaceThe Urban-Rural Divide Over Highway Expansion and EmissionsThe ratings firm expects Ireland to use pro

Here are the stocks making the biggest market moves midday.

Bank stocks surged broadly on Trump's win, with investors anticipating deregulation and pent-up M&A demand to be unlocked.

The recent U.S. presidential election results, including a Republican sweep, have raised questions about the future of renewable energy under President-elect Donald Trump’s leadership. Morgan Stanley’s report evaluates the economic impact on renewables under various policy scenarios and its effects on earnings. The analyst has adjusted its view on the clean tech industry to “In-Line” from “Attractive.” Also Read: Solar, Renewables Stocks Crash After Trump Win: Should You Buy Now At Cheap Valuati

“The customer is always right” is a credo that is often used and applies especially to consumer-facing businesses like Starbucks (SBUX). Throughout its history, the coffee franchise’s focus on the customer experience and product quality has paid off remarkably. After all, the Starbucks brand is estimated to be worth $60.7 billion, making it the 15th most valuable brand in the world. But even with all of this success, the company still has immense room for improvement. Indeed, Starbucks’ sales ha

Nvidia Corp's results in the coming week could guide the U.S. stock market on its next path, as investors turn their focus to the technology sector and artificial intelligence trade after an election-fueled rally stalled. A nearly 800% run in shares of Nvidia over the past two years, driven by its gold standard AI business, has propelled the semiconductor company to the world's top spot by market value. That heft gives Nvidia huge sway in market benchmarks, such as the S&P 500 and Nasdaq 100, while its results on Nov. 20 will also be a gauge for the market's appetite for tech stocks, the AI trade and sentiment for equities broadly, investors said.

On Friday, Vir Biotechnology, Inc. (NASDAQ:VIR) announced end-of-treatment data from Part B of the MARCH Phase 2 study evaluating combinations of tobevibart and elebsiran, with or without pegylated interferon alfa (PEG-IFNα), in participants with chronic hepatitis B. Chronic hepatitis B (CHB) is a long-lasting, inflammatory liver disease caused by the hepatitis B virus (HBV). The World Health Organization estimates that 254 million people live with CHB, and an estimated 1.1 million yearly deaths